Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

ClinicalTrials.gov ID: NCT06868212

Public ClinicalTrials.gov record NCT06868212. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihistamines

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3b study to evaluate efficacy of remibrutinib (25 mg twice daily \[b.i.d.\] by mouth \[p.o.\]) compared to dupilumab (600 mg loading dose administered subcutaneously (s.c.) followed by 300 mg every 2 weeks s.c.) at early timepoints (4 weeks and earlier), when administered as an add-on treatment to second generation H1-antihistamines (sgH1-AH) (standard label dose as background therapy) in adult US participants with moderate to severe chronic spontaneous urticaria (CSU) inadequately controlled by sgH1-AHs.

Study identification

NCT ID
NCT06868212
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
409 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 11, 2025 (Actual)
Primary completion
Feb 22, 2027 (Estimated)
Completion
May 17, 2027 (Estimated)
Last update posted
Oct 13, 2026

2025 – 2027

United States locations

U.S. sites
121
U.S. states
34
U.S. cities
101
Facility City State ZIP Site status
Allervie Clinical Research Birmingham Alabama 35209 —
Cahaba Derm and skin hlth ctr 27 Birmingham Alabama 35244 —
Research Solutions of Arizona Litchfield Park Arizona 85340 —
Peak Dermatology Payson Arizona 85541 —
Premier Allergy Asthma And Immunology Phoenix Arizona 85032 —
Orso Health Scottsdale Arizona 85254 —
Acuro Research Inc Little Rock Arkansas 72205 —
First OC Dermatology Fountain Valley California 92708 —
Ctr for Dermatology Clinical Res Fremont California 95438 —
Allergy and Asthma Specialists Group Huntington Beach California 92647 —
Orso Health Long Beach California 90808 —
Ark Clinical Research Long Beach California 90815 —
California Allergy and Asthma Medical Group Los Angeles California 90025 —
Dermatology Research Associates Los Angeles California 90045 —
One Of A Kind Clinical Research Napa California 94558 —
Stanford University Medical Center Palo Alto California 94304 —
Empire Clinical Research Pomona California 91767 —
Allergy and Asthma Consultants Redwood City California 94063 —
Norcal Clinical Research Rocklin California 95765 —
Peninsula Research Associates Rolling Hills Estates California 90274 —
Integrative Skin Science and Res Sacramento California 95815 —
UC Davis Neuromuscular Research Center Sacramento California 95817 —
Therapeutics Clinical Research San Diego California 92123 —
Dermatology Institute and Skin Care Santa Monica California 90403 —
Integrated Research of Inland Inc Upland California 91786 —
Allergy and Asthma Clin Res Inc Walnut Creek California 94598 —
University of Colorado Hospital - Aurora Aurora Colorado 80045 —
Asthma and Allergy Associates P C Colorado Springs Colorado 80907 —
Colorado ENT and Allergy Colorado Springs Colorado 80909 —
Howard University Hospital Division of Geriatrics Washington D.C. District of Columbia 20059 —
Florida Ctr Allergy Asthma Research Aventura Florida 33180 —
Skin Care Research Inc Boca Raton Florida 33486 —
Omnicure Clinical Research Doral Florida 33172 —
FXM Clinical Research Ft Laud Fort Lauderdale Florida 33308 —
Skin Care Research LLC Hollywood Florida 33021 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
University of MiamiHealth System Miami Florida 33125 —
FXM Clinical Res Miami LLC Miami Florida 33175 —
Miami Dade Medical Research Miami Florida 33176 —
Eminat LLC Miramar Florida 33027 —
Ziaderm Research LLC North Miami Beach Florida 33162 —
AllerVie Health Panama Florida 32405 —
Sarasota Clinical Research Sarasota Florida 34233 —
Lenus Research and Med Group LLC Sweetwater Florida 33172 —
Asthma Allergy Immunology Clin Res Tampa Florida 33613 —
Conquest Research Winter Park Florida 32789 —
AllerVie Clin Res Columbus GA Columbus Georgia 31904 —
Cleaver Medical Group Cumming Georgia 30040 —
Southeast Dermatology Specialists Douglasville Georgia 30135 —
Aeroallergy Research Laboratories Savannah Georgia 31406 —
The Allergy Group-Meridian Clinic Meridian Idaho 83642 —
NW Uni C and T Sciences Ins Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Midwest Allergy Sinus Asthma SC Normal Illinois 61761 —
Clinical Res Ctr of S Illinois O'Fallon Illinois 62269 —
Asthma and Allergy Center of Chicago S C River Forest Illinois 60305 —
Endeavor Health Clinical Trials Center Skokie Illinois 60077 —
Accellacare Duly Health and Care Wheaton Illinois 60189 —
Deaconess Clin Allerg Res Inst Evansville Indiana 47715 —
Southern IN Clinical Trials New Albany Indiana 47150 —
McFarland Clinic PC Ames Iowa 50010 —
Equity Medical LLC Bowling Green Kentucky 42104 —
Family Allergy And Asthma Rsch Inst Louisville Kentucky 40215 —
Allergy and Asthma Specialist P S C Owensboro Kentucky 42301 —
Ochsner Health Center Baton Rouge Louisiana 70816 —
Velocity Clinical Research Lafayette Louisiana 70508 —
Johns Hopkins U School of Med Baltimore Maryland 21205 —
Chesapeake Clinical Research Inc Baltimore Maryland 21236 —
Institute for Asthma and Allergy PC Chevy Chase Maryland 20815 —
Boston Specialists LLC Boston Massachusetts 02111 —
ClinSite Inc Ann Arbor Michigan 48106-0525 —
Derm Institute West Michigan PLLC Caledonia Michigan 49316 —
Henry Ford Hospital Detroit Michigan 48202 —
Revival Research Institute Troy Michigan 48084 —
Somerset Skin Centre Troy Michigan 48084 —
Clinical Research Institute Minneapolis Minnesota 55402 —
University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
ENT and Allergy Center of Missouri Columbia Missouri 65201 —
The Clinical Research Center St Louis Missouri 63141 —
Washington University St Louis Missouri 63141 —
Somnos Clinical Research Lincoln Nebraska 68510 —
Allergy and Asthma Center of Las Vegas Las Vegas Nevada 89128 —
Las Vegas Dermatology Las Vegas Nevada 89144 —
Circuit Clinical Mercer Algy Pulm Hamilton New Jersey 08619 —
Allergy Asthma Assoc Monmouth Little Silver New Jersey 07739 —
Allergy Partners of New Jersey PC Ocean Township New Jersey 07712 —
Equity Medical The Bronx New York 10455 —
Montefiore Medical Center The Bronx New York 10467 —
Allergy Partners Of West NC Asheville North Carolina 28801 —
UNC DermatologyandSkinCancer Ctr Chapel Hill North Carolina 27516 —
Bernstein Clinical Research Center Cincinnati Ohio 45231 —
CR Services Acquisition US Columbus Ohio 43213 —
Wright State University Fairborn Ohio 45324 —
Toledo Institute of Clinical Research Toledo Ohio 43617 —
Unity Clinical Research Oklahoma City Oklahoma 73118 —
Vital Prospects Clinical Research Institute Tulsa Oklahoma 74136 —
Oregon Medical Research Center Portland Oregon 97223 —
Oregon Health Sciences University Portland Oregon 97239 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Allergy and Clinical Immunology Associates Pittsburgh Pennsylvania 15241 —
Tribe Clinical Research LLC Greenville South Carolina 29601 —
Allergic Disease and Asthma Center Greenville South Carolina 29607 —
Charleston ENT and Allergy North Charleston South Carolina 29406 —
National Allergy and Asthma Research LLS North Charleston South Carolina 29420 —
Goodlettsville Dermatology Research Goodlettsville Tennessee 37072-2301 —
International Clinical Research Tennessee LCC Murfreesboro Tennessee 37130 —
Arlington Center for Dermatology Arlington Texas 76011 —
Orion Clinical Research Austin Texas 78759 —
Bellaire Dermatology Associates Bellaire Texas 77401 —
Reveal Research Institute Dallas Texas 75230 —
Pharma Research and Amp Consult Dallas Texas 75231 —
Western Sky Medical Research El Paso Texas 79924 —
Center for Clinical Studies Houston Texas 77030 —
Sante Clinical Research Kerrville Texas 78028 —
RFSA Dermatology San Antonio Texas 78213 —
Andante Research San Antonio Texas 78229 —
University Of Utah Murray Utah 84107 —
Allergy Associates of Utah Sandy City Utah 84093 —
Forefront Dermatology Vienna Virginia 22182 —
Bellingham Asthma Allergy and Immunology Bellingham Washington 98225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06868212, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06868212 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →